BioCentury
ARTICLE | Clinical News

IV elamipretide: Phase II data

October 10, 2016 7:00 AM UTC

The double-blind, U.S. Phase II MOTION trial in 40 patients ages 60-85 with documented mitochondrial dysfunction showed that a single infusion of 0.25 mg/kg/hour IV elamipretide given over 2 hours imp...